PHARMANUTRA - PHN - GUIDELINES OF THE BOD TO SHAREHOLDERS ON THE FUTURE SIZE AND COMPOSITION OF THE NEW BOD - APPOINTMENT OF THE INVESTOR RELATIONS DIRECTOR

Protocollo

177775

Comunicato

Azienda

PHARMANUTRA

Tipo

Comunicato

SDIR

SDIRNIS

Lingua

ENG

Data creazione

Mon, 02/23/2026 - 19:01

Data ricezione SDIR

Mon, 02/23/2026 - 19:01

Data embargo SDIR

Mon, 02/23/2026 - 19:01

Data diffusione SDIR

Mon, 02/23/2026 - 19:01

Mercato

Euronext Star Milan